(Q74106296)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10924782%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Can monovalent hepatitis A and B vaccines be replaced by a combined hepatitis A/B vaccine during the primary immunization course? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10924782%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10924782%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

B Kallinowski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10924782%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A Knöll

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10924782%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

E Lindner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10924782%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

R Sänger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10924782%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J Vollmar

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10924782%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

B Zieger

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10924782%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

W Jilg

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10924782%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

English

0 references

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10924782%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10924782%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10924782%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10924782%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

16-22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10924782%20AND%20SRC:MED&resulttype=core&format=json

Antibody against hepatitis A in seven European countries. I. Comparison of prevalence data in different age groups

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900166-3

7 January 2021

The case for routine childhood vaccination against hepatitis A

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900166-3

7 January 2021

Vaccines to prevent viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900166-3

7 January 2021

Vaccination of travelers against hepatitis A and B.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900166-3

7 January 2021

Production of antibody to hepatitis A virus and hepatitis B surface antigen measured after combined hepatitis A/hepatitis B vaccination in 242 adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900166-3

7 January 2021

The first combined vaccine against hepatitis A and B: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900166-3

7 January 2021

Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900166-3

7 January 2021

Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900166-3

7 January 2021

Over a decade of experience with a yeast recombinant hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900166-3

7 January 2021

Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900166-3

7 January 2021

Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900166-3

7 January 2021

Safety and immunogenicity of a combined hepatitis A and hepatitis B vaccine in young healthy adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900166-3

7 January 2021

Interference of Antibody Production to Hepatitis B Surface Antigen in a Combination Hepatitis A/Hepatitis B Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900166-3

7 January 2021

10.1016/S0264-410X(00)00166-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10924782%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference